WEBINAR

 

 

Differences between Worker Safety and Product Safety Evaluations in Contract Manufacturing Operations

May 11, 2010 WEBINAR

12 - 1:30 pm EST

 

Registration fee for one dial-in, one person.  Call for discounts to register more than one person

This webinar will guide you through the development of various health-based risk assessments used to ensure occupational health and product safety.

In this webinar you will:

• Review the unique role of contract manufacturers in the protection of worker health and product safety

• Identify the roles and responsibilities of CMOs and drug innovators in developing health-based risk assessments

• Discuss the history of occupational health categorization and banding systems

• Understand how the assignment of control bands are linked to appropriate handling recommendations

• Use data generated in the drug development process to set airborne limits for active pharmaceuticals

• Compare the development of airborne limits to those for worker contact surfaces
  

•  Highlight differences between worker contact surface and product contact surfaces

FEE:  Priced per person

Instructor:  Robert G. Sussman, Ph.D., DABT

Bob is currently the Managing Principal of SafeBridge Consultants’ Eastern Operations.  He has 20 years experience in the pharmaceutical industry where he has worked in various capacities in corporate occupational toxicology groups for Warner-Lambert and Pfizer.  Bob has an undergraduate degree in Bioenvironmental Engineering from Brown University and a Ph.D. in Environmental Health Science from NYU.  He is a Diplomate of the American Board of Toxicology, a past member and chair of the AIHA’s WEEL Committee, and a founding member of the Occupational Toxicology Roundtable.  He also has an adjunct appointment at the NYU Medical Center where he gives several lectures each year on regulatory toxicology, risk assessment, and industrial hygiene aspects of the pharmaceutical industry.